Related references
Note: Only part of the references are listed.Simultaneous estimation of E- and Z-isomers of guggulsterone in rabbit plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic study
R. S. Bhatta et al.
BIOMEDICAL CHROMATOGRAPHY (2011)
Effect of Sanguis draconis (a dragon's blood resin) on streptozotocin- and cytokine-induced β-cell damage, in vitro and in vivo
Chien-Ming Hua et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species
Leila Hosseinzadeh et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Protective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, against lipopolysaccharide-induced inflammation in RAW264.7 macrophages
Ching-Chiung Wang et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2011)
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications
Hilmar Vidarsson et al.
STEM CELL REVIEWS AND REPORTS (2010)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells
Hong Xin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Oxidative stress and calpain inhibition induce alpha B-crystallin phosphorylation via p38-MAPK and calcium signalling pathways in H9c2 cells
Ioanna-Katerina S. Aggeli et al.
CELLULAR SIGNALLING (2008)
Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine
Tao Shen et al.
CHEMISTRY & BIODIVERSITY (2008)
Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells
Xiuzhen Han et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors
Tobias Eltze et al.
MOLECULAR PHARMACOLOGY (2008)
Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin
Tomas G. Neilan et al.
CIRCULATION (2007)
Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-κB activation
Do-Sung Kim et al.
LIFE SCIENCES (2007)
Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials
Aalt Bast et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity
P. Menna et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin
K Li et al.
CIRCULATION (2006)
Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up
L Elbl et al.
SUPPORTIVE CARE IN CANCER (2006)
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Malgorzata Tokarska-Schlattner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity
PW Fisher et al.
CIRCULATION (2005)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Guggulsterone inhibits NF-κB and IκBα kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis
S Shishodia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo
R Sugioka et al.
ONCOGENE (2003)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents
MR Meselhy
PHYTOCHEMISTRY (2003)
A natural product that lowers cholesterol as an antagonist ligand for FXR
NL Urizar et al.
SCIENCE (2002)
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
B Kalyanaraman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Share Paper
